pde-neoⅡ Near infrared fluorescence imager: C10935-400
Observation of blood vessels Camera systems to visualize blood vessels and tissue perfusion in real time by observing the fluorescence emitted by ICG dye. This is a medical device cleared in USA, Canada.
To further accelerate R&D work for novel coronavirus (COVID-19) test reagents, Hamamatsu Photonics has developed a new fluorescence immunochromato reader with both high sensitivity and high reproducibility
Hamamatsu Photonics have developed a new “Immunochromato Reader C10066-60” that gives precise readout of fluorescence in immunochromatographic reagents. By applying our own advanced signal processing and optical design technology, the measurement sensitivity has increased more than 10 times higher than currently available products.
This new immunochromato reader (lateral flow reader) high-sensitivity detection of reagent reactions occurring with antigens such as viruses and hormones or antibodies reacting with viruses, etc. It is a promising tool for streamlining R&D work on immunochromatographic reagents including those for novel coronavirus (COVID-19). We started accepting product orders from domestic and overseas reagent manufacturers on October 1st 2020. We will also be supplying this immunochromato reader as a commercially available OEM (original equipment manufacturer) product that matches the reagents produced by each manufacturer.
Hamamatsu Photonics is dedicated to improving life through light-based technologies. Based on this corporate philosophy, we conduct research on the fundamental properties of light and develop products in the fields of photomultipliers, photodiodes, infrared detectors, image sensors, scientific cameras and light sources. We offer X-ray detectors and sources as well as special photometric systems for semiconductor manufacturing, pharmaceutical development, non-destructive testing and academic research.